Indeed, analysis of clinical BC samples revealed that high expression of ZBTB11 was associated with both the clinical staging and poor prognosis in BC patients, which implies that it may be a crucial transcription factor for maintaining BC tumorigenesis. This evidence concerns the gene ZBTB11 and breast cancer.